WASHOUGAL, WA, Feb. 22, 2018 -- This week in Bev Industry News we report on the high-growth functional beverage sector and highlight publicly-traded Glucose Health -- ticker (OTC PINK: GLUC) -- which makes "diabetic-friendly" iced tea, now sold nation-wide in 1800 Walmart locations.
With beverage industry giants spending billions to offset declining soda sales, by acquiring the upstart beverage companies making the new healthy drinks today's consumers demand... there has never been a better time to capitalize on the red-hot functional beverage sector.
Today, consumers are looking for beverages to offer far more than just satisfying thirst. The beverage industry's product response are collectively known as functional beverages. Leading the growth in functional beverages is functional tea beverages. Euromonitor calculates functional tea beverages will achieve an impressive 10.3% CAGR (compound annual growth rate) through the year 2020 – more than any other functional beverage category including energy and (bottled) water.
The amazing popularity of functional beverages with consumers is no surprise to early investors in two functional "tea" beverage start-ups recently acquired for astonishing multiples of their revenues. This week's article takes an in-depth look at the companies producing these unique and profitable new functional tea beverages including Glucose Health, which makes "diabetic-friendly" iced tea, now sold nation-wide in 1800 Walmart locations.
For the full article visit http://bevindustrynews.com/
About Bev Industry News
Bev industry news covers the latest news and trends from the beverage industry.
About Glucose Health, Inc.
Glucose Health, Inc. is the manufacturer of Glucose Health® Diabetic-Friendly Iced Tea Mix -- the first iced tea mix made in America sweetened without sugar and fortified with additional ingredients to help maintain healthy blood sugar, triglyceride and cholesterol levels and regular digestive health.
CONTACT INFORMATION
Contact:
Marc Hatch
[email protected]


ByteDance Advances AI Chip Development With Samsung Manufacturing Talks
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Amazon Explores AI Content Marketplace With Media Publishers
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Cloudflare Forecasts Strong Revenue Growth as AI Fuels Cloud Services Demand
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss
Samsung Electronics Shares Jump on HBM4 Mass Production Report 



